This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Kayal Madhivanan, PhD
Senior Scientist at Arrowhead Pharmaceuticals
Speaker

Profile

Kayal Madhivanan is a Senior Scientist at Arrowhead Pharmaceuticals, where she works across target evaluation, translational research, and cross-functional program development to advance therapies for neurological diseases. She brings deep expertise in cellular and molecular biology, protein trafficking, and CNS biology. Prior to Arrowhead, she was a Project Scientist at UC San Diego, building pipelines to study Parkinson's disease pathophysiology using CRISPR and optical electrophysiology. As a George E. Hewitt Foundation Postdoctoral Fellow at The Scripps Research Institute, she developed the first C. elegans model of TTR amyloidosis, uncovering therapeutic strategies for neuronal dysfunction.

Agenda Sessions

  • Systemic RNAi Targeting MAPT: Advancing Tau Suppression Across the CNS with TRiM™ SC

    4:45pm